Wolfgang Bogner1,
2, Aaron T. Hess3, Borjan Gagoski4, Matthew Dylan
Tisdall1, Andr J. W. van der Kouwe1, Siegfried
Trattnig2, Ovidiu C. Andronesi1
1Athinoula
A. Martinos Center for Biomedical Imaging, Department of Radiology,
Massachusetts General Hospital, Harvard Medical School, Boston, MA, United
States; 2MR Center of Excellence, Department of Radiology, Medical
University Vienna, Vienna, Austria; 3Department of Cardiovascular Medicine,
University of Oxford, Oxford, United Kingdom; 4Fetal-Neonatal
Neuroimaging & Developmental Science Center, Childrens Hospital Boston,
Harvard Medical School, Boston, MA, United States
High-field MR spectroscopic imaging (MRSI) is limited by localization artifacts (i.e., imperfect selection profiles, chemical shift errors, B1 inhomogeneities), motion-related artifacts (i.e., position changes, phase artifacts, B0 changes, lipid artifacts), and long measurement times (i.e., causing reduced spatial coverage and low spatial resolution).